Сегодня 27 сентября 2023
Медикус в соцсетях
Задать вопрос

ЗАДАТЬ ВОПРОС РЕДАКТОРУ РАЗДЕЛА (ответ в течение нескольких дней)

Не публикуется
служит для обратной связи
Антиспам - не удалять!
Ваш вопрос:
Получать ответы и новости раздела
17 мая 2002 00:00   |   Emmanuel Martinod, MD*a, Alexandre D’Audiffret, MDa, Pascal Thomas, MDb, Alain J. Wurtz, MDc, Marcel Dahan, MDd, Marc Riquet, MDe, Antoine Dujon, MDf, René Jancovici, MDg, Roger Giudicelli, MDb, Pierre Fuentes, MDb, Jacques F. Azorin, MDa

Management of superior sulcus tumors: experience with 139 cases treated by surgical resection

Background. The management of non-small cell carcinomas of the lung involving the superior sulcus remains controversial. The goal of this retrospective study was to evaluate the role of surgery, radiotherapy, and chemotherapy for the treatment of superior sulcus tumors, to define the best surgical approach for radical resection, and to identify factors influencing long-term survival.
Methods. Between 1983 and 1999, 139 patients underwent surgical resection of superior sulcus tumors in seven thoracic surgery centers. According to the classification of the American Joint Committee, 51.1% of cancers were stage IIB, 13.7% stage IIIA, 32.4% stage IIIB, and 2.9% stage IV.
Results. The resections were performed with 74.1% using the posterior approach and 25.9% using an anterior approach. A lobectomy was accomplished in 69.8% of the cases and a wedge resection in 22.3%. Resection of a segment of vertebrae or subclavian artery was performed, respectively, in 19.4% and 18% of the cases. Resection was complete in 81.3% of cancers. The overall 5−year survival rate was 35%. Preoperative radiotherapy improved 5−year survival for stages IIB–IIIA. Surgical approach, postoperative radiotherapy, or chemotherapy did not change survival.
Conclusions. The optimal treatment for superior sulcus tumors is complete surgical resection. The surgical approach (anterior/posterior) did not influence the 5−year survival rate. Preoperative radiotherapy should be recommended to improve outcome of patients with a superior sulcus tumor.


Смотри также
17 мая 2002  |  00:05
Usefulness of videothoracoscopic intrapericardial examination of pulmonary vessels to identify resectable clinical T4 lung cancer
Background. Discrepancies in predicting resectability by imaging techniques (computed tomography and magnetic resonance imaging) compared with actual intraoperative findings have persuaded us
17 мая 2002  |  00:05
Cell membrane fluidity and prognosis of lung cancer
Background. Membranes of tumor cells have been found to posses higher fluidity than membranes of nontumor cells. Plasma membrane fluidity is significantly correlated with malignant potential of
17 мая 2002  |  00:05
Pulmonary blastoma: medium-term results from a regional center
Background. Pulmonary blastomas are rare lung tumors that morphologically resemble fetal pulmonary structure and can exist in two forms, biphasic and monophasic. We reviewed our experience over
17 мая 2002  |  00:05
Neural networks as a prognostic tool of surgical risk in lung resections
Background. Assessment of surgical risk in patients undergoing pulmonary resection is a fundamental goal for thoracic surgeons. Usually used risk indices do not predict the individual outcome.
17 мая 2002  |  00:05
Natriuretic peptides after pulmonary resection
Background. Little is known about alterations in the levels and influence of natriuretic peptide (NP) on cardiopulmonary function after pulmonary resection for lung cancer. This study was designed